CLINICAL, SUBCLINICAL IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA AT PHAM NGOC THACH HOSPITAL
Main Article Content
Abstract
Objectives: To describes the prevalence and clinical, laboratory of community-acquired pneumonia patients at Pham ngoc Thach Hospital. Patients and methods: A prospective cohort study, combining retrospective medical record reviews, was conducted on patients diagnosed with community-acquired pneumonia at Pham Ngoc Thach Hospital from January to October 2022. Results: The mean age of patients was 62 (52-72) years. Male patients (69.7%) were more common than female patients (30.3%). The most common comorbidity among community-acquired pneumonia patients was hypertension. Common clinical symptoms included cough (95.9%), dyspnea (87.6%), fever (85.5%), and sputum production (75.9%). The median value of white blood cell count was 13.2 x 109/L and the median value of CRP was 45.3 mg/L. Lung parenchymal involvement on chest X-ray was predominantly observed as interstitial infiltrates (91.0%). Conclusion: Community-acquired pneumonia primarily affects the elderly population (over 65 years old), with males being more affected than females. Common clinical symptoms include cough, dyspnea, fever, and sputum production. Elevated CRP levels are common, and the majority of patients exhibit lung parenchymal involvement on chest X-ray
Article Details
Keywords
Community Acquired Pneumonia, clinical, subclinical
References
2. World Health Organization. The top 10 causes of death. Accessed March 7, 2024. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
3. Bộ Y tế. Hướng Dẫn Chẩn Đoán và Điều Trị Viêm Phổi Mắc Phải Cộng Đồng ở Người Lớn.; 2020:7-45.
4. Tạ Thị Diệu Ngân. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và căn nguyên của viêm phổi mắc phải tại cộng đồng. Đại học Y Hà Nội; 2016.
5. Liapikou A, Ferrer M, Polverino E, Balasso V, Esperatti M, Piñer R. Severe Community-Acquired Pneumonia: Validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to Predict an Intensive Care Unit Admission. Clinical Infectious Diseases. 2009;48(4):377-385. doi:10.1086/596307
6. Salih W, Schembri S, Chalmers JD. Simplification of the IDSA/ATS criteria for severe CAP using meta-analysis and observational data. European Respiratory Journal. 2014;43(3):842-851. doi:10.1183/09031936.00089513
7. Chalmers JD, Taylor JK, Mandal P, et al. Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. Clin Infect Dis. 2011;53(6):503-511. doi:10.1093/cid/cir463
8. Tokgoz Akyil F, Yalcinsoy M, Hazar A, et al. Prognosis of hospitalized patients with community-acquired pneumonia. Pulmonology. Published online February 17, 2018. doi:10.1016/j.rppnen.2017.07.010.
9. Lim HF, Phua J, Mukhopadhyay A, et al. IDSA/ATS minor criteria aid pre-intensive care unit resuscitation in severe community-acquired pneumonia. EurRespir J. Mar 2014;43(3):852-62. doi:10.1183/09031936.0008171